Abstract
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation in the joints. Although methotrexate (MX) is the first-line treatment, side effects are common. This study aimed to investigate the effects of quercetin (QT) and/or MX on inflammation and systemic toxicity in a rat model of RA. Male Wistar rats were divided into control (C), RA, QT, MX, and QT + MX groups (n=6). The RA induction consisted of three intra-articular injections of methylated bovine serum albumin (1×/week) in the temporomandibular joint (TMJ). QT (25 mg/kg) and/or MX (0.75 mg) administration occurred by oral gavage daily. We performed mechanical hyperalgesia in TMJ, leukocyte recruitment in synovial fluid, histopathology, and immunohistochemistry (TNF-α, IL-17, and IL-10) in synovial membrane and toxicity parameters. The RA showed a reduction in the nociceptive threshold (p<0.001), increase in leukocyte recruitment in synovial fluid (p<0.001), intense inflammatory infiltrate (p<0.001), and intense immunoexpression of TNF-α, IL-17, and IL-10 in the synovial membrane (p<0.001) compared to C (p<0.001). QT and/or MX therapy reduced inflammatory parameters (p<0.001). However, downregulation of IL-10 was observed only in the groups that received MX (p<0.001). Leukocytosis was seen in RA (p<0.05), but QT and/or MX reversed it (p<0.05). MX was associated with pathological changes in the liver and higher levels of transaminases when compared to the other groups (p<0.05). QT co-administered with MX reversed this hepatotoxicity (p<0.05). There were no alterations in the kidney between the groups (p>0.05). QT has potential to support MX therapy, showing anti-inflammatory and hepatoprotective effects in this model.
Similar content being viewed by others
References
Aletaha, D., J.S. Smolen, and J. S. 2018. Diagnosis and management of rheumatoid arthritis: a review. Jama 320: 1360–1372. https://doi.org/10.1001/jama.2018.13103.
Lin, C.Y., C.H. Chung, H.Y. Chu, L.C. Chen, K.H. Tu, C.H. Tsao, et al. 2017. Prevalence of Temporomandibular Disorders in Rheumatoid Arthritis and Associated Risk Factors: A Nationwide Study in Taiwan. Journal of Oral & Facial Pain & Headache 31: e29–e36. https://doi.org/10.11607/ofph.1917.
González-Chávez, S.A., C. Pacheco-Tena, T. de Jesús Caraveo-Frescas, C.M. Quiñonez-Flores, G. Reyes-Cordero, and R.M. Campos-Torres. 2020. Oral health and orofacial function in patients with rheumatoid arthritis. Rheumatology International 40: 445–453. https://doi.org/10.1007/s00296-019-04440-3.
Friedman, B., and B. Cronstein. 2019. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine 86: 301–307. https://doi.org/10.1016/j.jbspin.2018.07.004.
Alam, J., I. Jantan, and S.N.A. Bukhari. 2017. Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy. Biomedicine & Pharmacotherapy 92: 615–633. https://doi.org/10.1016/j.biopha.2017.05.055.
Yu, J., and P. Zhou. 2020. The advances of methotrexate resistance in rheumatoid arthritis. Inflammopharmacology 4: 1–11. https://doi.org/10.1007/s10787-020-00741-3.
Wang, W., H. Zhou, and L. Liu. 2018. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. European Journal of Medicinal Chemistry 158: 502–516. https://doi.org/10.1016/j.ejmech.2018.09.027.
Basu, A., J. Schell, and R.H. Scofield. 2018. Dietary fruits and arthritis. Food & Function 9: 70–77. https://doi.org/10.1039/c7fo01435j.
Gardi, C., K. Bauerova, B. Stringa, V. Kuncirova, L. Slovak, S. Ponist, F. Drafi, L. Bezakova, I. Tedesco, A. Acquaviva, S. Bilotto, and G.L. Russo. 2015. Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis. Archives of Biochemistry and Biophysics 583: 150–157. https://doi.org/10.1016/j.abb.2015.08.008.
Salehi, B., L. Machin, L. Monzote, J. Sharifi-Rad, S.M. Ezzat, M.A. Salem, et al. 2020. Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health. ACS Omega. https://doi.org/10.1021/acsomega.0c01818.
Andres, S., S. Pevny, R. Ziegenhagen, N. Bakhiya, B. Schäfer, K.I. Hirsch-Ernst, and A. Lampen. 2018. Safety aspects of the use of quercetin as a dietary supplement. Molecular Nutrition & Food Research 62: 1700447. https://doi.org/10.1002/mnfr.201700447.
Xiong, G., W. Ji, F. Wang, F. Zhang, P. Xue, M. Cheng, Y. Sun, X. Wang, and T. Zhang. 2019. Quercetin inhibits inflammatory response induced by LPS from porphyromonas gingivalis in human gingival fibroblasts via suppressing NF-κB signaling pathway. BioMed Research International e2019: 1–10. https://doi.org/10.1155/2019/6282635.
Chen, S., H. Jiang, X. Wu, and J. Fang. 2016. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators of Inflammation e2016: 1–16. https://doi.org/10.1155/2016/9340637.
Ren, K.W., Y.H. Li, G. Wu, J.Z. Ren, H.B. Lu, Z.M. Li, and X.W. Han. 2017. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. International Journal of Oncology 50: 1299–1311. https://doi.org/10.3892/ijo.2017.3886.
Haleagrahara, N., K. Hodgson, S. Miranda-Hernandez, S. Hughes, A.B. Kulur, and N. Ketheesan. 2018. Flavonoid quercetin–methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis. Inflammopharmacology 26: 1219–1232. https://doi.org/10.1007/s10787-018-0480-2.
Gokhale, J.P., H.S. Mahajan, and S.J. Surana. 2019. Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: In vivo and in vitro studies. Biomedicine & Pharmacotherapy 112: 108622. https://doi.org/10.1016/j.biopha.2019.108622.
Pan, F., L. Zhu, H. Lv, and C. Pei. 2016. Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1. International Journal of Molecular Medicine 38: 1507–1514. https://doi.org/10.3892/ijmm.2016.2755.
Haleagrahara, N., S. Miranda-Hernandez, M.A. Alim, L. Hayes, G. Bird, and N. Ketheesan. 2017. Therapeutic effect of quercetin in collagen-induced arthritis. Biomedicine & Pharmacotherapy 90: 38–46. https://doi.org/10.1016/j.biopha.2017.03.026.
Javadi, F., A. Ahmadzadeh, S. Eghtesadi, N. Aryaeian, M. Zabihiyeganeh, A. Rahimi Foroushani, and S. Jazayeri. 2017. The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: a double-blind, randomized controlled trial. Journal of the American College of Nutrition 36: 9–15. https://doi.org/10.1080/07315724.2016.1140093.
de Sousa, L.M., J.M. dos Santos Alves, C. da Silva Martins, K.M.A. Pereira, P. Goes, and D.V. Gondim. 2019. Immunoexpression of canonical Wnt and NF-κB signaling pathways in the temporomandibular joint of arthritic rats. Inflammation Research 68: 889–900. https://doi.org/10.1007/s00011-019-01274-4.
Azevedo, M.I., A.F. Pereira, R.B. Nogueira, F.E. Rolim, G.A. Brito, D.V.T. Wong, R.C.P. Lima-Júnior, R. de Albuquerque Ribeiro, and M.L. Vale. 2013. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Molecular Pain 9: 1744–8069. https://doi.org/10.1186/1744-8069-9-53.
Gondim, D.V., J.L. Costa, S.S.G.A.D.C. Rocha, R.D. Brito, A. Ribeiro, and M.L. Vale. 2012. Antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint. Canadian Journal of Physiology and Pharmacology 90: 395–405. https://doi.org/10.1139/y2012-003.
Denadai-Souza, A., L. de Lucca Camargo, M.T. Ribela, J.E. Keeble, S.K. Costa, and M.N. Muscará. 2009. Participation of peripheral tachykinin NK1 receptors in the carrageenan-induced inflammation of the rat temporomandibular joint. European Journal of Pain 13: 812–819. https://doi.org/10.1016/j.ejpain.2008.09.012.
Chaves, H.V., R.D.A. Ribeiro, A.M.B. de Souza, A.S. Gomes, M.L. Vale, M.M. Bezerra, and G.A.D.C. Brito. 2011. Experimental model of zymosan-induced arthritis in the rat temporomandibular joint: role of nitric oxide and neutrophils. Journal of Biomedicine and Biotechnology e2011: 707985. https://doi.org/10.1155/2011/707985.
Brizeno, L.A.C., A.M.S. Assreuy, A.P.N. Alves, F.B. Sousa, P.G.D.B. Silva, S.C.O. Sousa, et al. 2016. Delayed healing of oral mucosa in a diabetic rat model: Implication of TNF-α, IL-1β and FGF-2. Life Sciences 155: 36–47. https://doi.org/10.1016/j.lfs.2016.04.033.
Guimarães, M.V., I.M. Melo, V.M.A. Araújo, D.V.T. Wong, C.S.R. Fonteles, L.K.A.M. Leal, et al. 2016. Dry Extract of Matricaria recutita L.(Chamomile) Prevents Ligature-Induced Alveolar Bone Resorption in Rats via Inhibition of Tumor Necrosis Factor-α and Interleukin-1β. Journal of Periodontology 87: 706–715. https://doi.org/10.1902/jop.2016.150411.
Teixeira, A.H., J.M. Freire, L.H. de Sousa, A.T. Parente, N.A. de Sousa, A. Arriaga, et al. 2017. Stemodia maritima L. extract decreases inflammation, oxidative stress, and alveolar bone loss in an experimental periodontitis rat model. Frontiers in Physiology 8: 988. https://doi.org/10.3389/fphys.2017.00988.
Quinteiro, M.S., M.H. Napimoga, K.P. Mesquita, and J.T. Clemente-Napimoga. 2012. The indirect antinociceptive mechanism of 15 d-PGJ 2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats. European Journal of Pain 16: 1106–1115. https://doi.org/10.1002/j.1532-2149.2012.00114.x.
Bas, D.B., J. Su, G. Wigerblad, and C.I. Svensson. 2016. Pain in rheumatoid arthritis: models and mechanisms. Pain Management 6: 265–284. https://doi.org/10.2217/pmt.16.4.
Sessle, B.J. 2011. Peripheral and central mechanisms of orofacial inflammatory pain. International Review of Neurobiology 97: 179–206. https://doi.org/10.1016/B978-0-12-385198-7.00007-2.
Napimoga, M.H., G.R. Souza, T.M. Cunha, L.F. Ferrari, J.T. Clemente-Napimoga, C.A. Parada, W.A. Verri Jr., F.Q. Cunha, and S.H. Ferreira. 2008. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. Journal of Pharmacology and Experimental Therapeutics 324: 313–321. https://doi.org/10.1124/jpet.107.126045.
Sakuraba, K., K. Fujimura, Y. Nakashima, K. Okazaki, J.I. Fukushi, M. Ohishi, A. Oyamada, Y. Esaki, H. Miyahara, Y. Iwamoto, Y. Yoshikai, and H. Yamada. 2015. Brief Report: Successful In Vitro Culture of Rheumatoid Arthritis Synovial Tissue Explants at the Air–Liquid Interface. Arthritis & Rheumatology 67: 887–892. https://doi.org/10.1002/art.39019.
Penatti, A., F. Facciotti, R. de Matteis, P. Larghi, M. Paroni, A. Murgo, O. de Lucia, M. Pagani, L. Pierannunzii, M. Truzzi, A. Ioan-Facsinay, S. Abrignani, J. Geginat, and P.L. Meroni. 2017. Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis. Arthritis Research & Therapy 19: 1–9. https://doi.org/10.1186/s13075-017-1305-1.
McInnes, I.B., C.D. Buckley, and J.D. Isaacs. 2016. Cytokines in rheumatoid arthritis—shaping the immunological landscape. Nature Reviews Rheumatology 12: 63–68. https://doi.org/10.1038/nrrheum.2015.171.
Roeleveld, D.M., and M.I. Koenders. 2015. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy. Cytokine 74: 101–107. https://doi.org/10.1016/j.cyto.2014.10.006.
Robert, M., and P. Miossec. 2019. IL-17 in rheumatoid arthritis and precision medicine: from synovitis expression to circulating bioactive levels. Frontiers in Medicine 5: 364. https://doi.org/10.3389/fmed.2018.00364.
Hot, A., and P. Miossec. 2011. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Annals of the Rheumatic Diseases 70: 727–732. https://doi.org/10.1136/ard.2010.143768.
Tsukamoto, M., N. Seta, K. Yoshimoto, K. Suzuki, K. Yamaoka, and T. Takeuchi. 2017. CD14 bright CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis. Arthritis Research & Therapy 19: 28. https://doi.org/10.1186/s13075-016-1216-6.
Ummarino, D. 2017. Defective IL-10-producing B reg cells. Nature Reviews Rheumatology 13: 132–132. https://doi.org/10.1038/nrrheum.2017.10.
Katsikis, P.D., C.Q. Chu, F.M. Brennan, R.N. Maini, and M. Feldmann. 1994. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. The Journal of Experimental Medicine 179: 1517–1527. https://doi.org/10.1084/jem.179.5.1517.
Marinou, I., J. Healy, D. Mewar, D.J. Moore, M.C. Dickson, M.H. Binks, D.S. Montgomery, K. Walters, and A.G. Wilson. 2007. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis & Rheumatology 56: 2549–2556. https://doi.org/10.1002/art.22814.
Kawaguchi, K., M. Kaneko, R. Miyake, H. Takimoto, and Y. Kumazawa. 2019. Potent Inhibitory Effects of Quercetin on Inflammatory Responses of Collagen-Induced Arthritis in Mice. Endocrine, Metabolic & Immune Disorders-Drug Targets 19: 308–315. https://doi.org/10.2174/1871530319666190206225034.
Noack, M., and P. Miossec. 2019. Effects of Methotrexate Alone or Combined With Arthritis-Related Biotherapies in an in vitro Co-culture Model With Immune Cells and Synoviocytes. Frontiers in Immunology 10: 2992. https://doi.org/10.3389/fimmu.2019.02992.
Milenković, M., N. Arsenović-Ranin, Z. Stojić-Vukanić, B. Bufan, D. Vučićević, and I. Jančić. 2010. Quercetin ameliorates experimental autoimmune myocarditis in rats. Journal of Pharmacy & Pharmaceutical Sciences 13: 311–319. https://doi.org/10.18433/j3vs3s.
Inoue, K., and H. Yuasa. 2014. Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy. Drug Metabolism and Pharmacokinetics 29: 12–19. https://doi.org/10.2133/dmpk.dmpk-13-rv-119.
Syed, K.M., and R.S. Pinals. 1996. Leukocytosis in rheumatoid arthritis. Journal of Clinical Rheumatology 2: 197–202. https://doi.org/10.1097/00124743-199608000-00007.
Das, S., and P. Padhan. 2017. An overview of the extraarticular involvement in rheumatoid arthritis and its management. Journal of Pharmacology & Pharmacotherapeutics 8: 81. https://doi.org/10.4103/jpp.JPP_194_16.
Radovanović-Dinić, B., S. Tešić-Rajković, V. Zivkovic, and S. Grgov. 2018. Clinical connection between rheumatoid arthritis and liver damage. Rheumatology International 38: 715–724. https://doi.org/10.1007/s00296-018-4021-5.
Conway, R., and J.J. Carey. 2017. Risk of liver disease in methotrexate treated patients. World Journal of Hepatology 9: 1092–1100. https://doi.org/10.4254/wjh.v9.i26.1092.
Cojocaru, M., I.M. Cojocaru, I. Silosi, and C.D. Vrabie. 2013. Liver involvement in patients with systemic autoimmune diseases. Maedica 8: 394.
Miltonprabu, S., M. Tomczyk, K. Skalicka-Woźniak, L. Rastrelli, M. Daglia, S.F. Nabavi, S.M. Alavian, and S.M. Nabavi. 2017. Hepatoprotective effect of quercetin: From chemistry to medicine. Food and Chemical Toxicology 108: 365–374. https://doi.org/10.1016/j.fct.2016.08.034.
Huang, Z.Q., P. Chen, W.W. Su, Y.G. Wang, H. Wu, W. Peng, and P.B. Li. 2018. Antioxidant activity and hepatoprotective potential of quercetin 7-rhamnoside in vitro and in vivo. Molecules 23: 1188. https://doi.org/10.3390/molecules23051188.
Acknowledgements
The authors gratefully acknowledge the Nucleus of Studies in Microscopy and Imaging Processing (NEMPI) and the Laboratory of Inflammation and Cancer (LAFICA) of Federal University of Ceará.
Availability of Data and Material
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
Author information
Authors and Affiliations
Contributions
A.C.F.C., L.M.S. and J.M.S.A. performed animal and laboratory experiments. A.C.F.C., L.M.S., K.M.A.P., A.P.N.N.A., P.G and D.V.G contributed to data analysis and interpretation. A.C.F.C. wrote a draft of the manuscript. D.V.G and M.L.V. contributed to the concept and design of the study. D.V.G coordinated the experiments and critically reviewed the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
The experimental procedures were approved by the Ethical Committee on Animal Use (CEUA) of the Federal University of Ceará, Brazil with number protocol 148/17, according with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications no 8023, revised 1978) and the ARRIVE guidelines UK.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Costa, A.C.d.F., de Sousa, L.M., dos Santos Alves, J.M. et al. Anti-inflammatory and Hepatoprotective Effects of Quercetin in an Experimental Model of Rheumatoid Arthritis. Inflammation 44, 2033–2043 (2021). https://doi.org/10.1007/s10753-021-01479-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-021-01479-y